Septerna (SEPN) Expected to Announce Earnings on Wednesday

Septerna (NASDAQ:SEPN - Get Free Report) is expected to announce its quarterly earnings data before the market opens on Wednesday, February 19th. Analysts expect the company to announce earnings of ($0.56) per share for the quarter.

Septerna Trading Up 12.2 %

SEPN traded up $1.41 during midday trading on Friday, hitting $12.96. 198,879 shares of the company were exchanged, compared to its average volume of 221,678. The business has a 50 day moving average price of $19.35. Septerna has a 1-year low of $10.34 and a 1-year high of $28.99.

Analyst Ratings Changes

SEPN has been the topic of several analyst reports. TD Cowen began coverage on Septerna in a report on Tuesday, November 19th. They issued a "buy" rating on the stock. Cantor Fitzgerald reiterated an "overweight" rating and set a $50.00 price objective on shares of Septerna in a research report on Tuesday. Wells Fargo & Company began coverage on shares of Septerna in a report on Tuesday, November 19th. They issued an "overweight" rating and a $43.00 target price on the stock. Finally, JPMorgan Chase & Co. started coverage on Septerna in a report on Tuesday, November 19th. They set an "overweight" rating and a $38.00 price target for the company.

Septerna Company Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.